首页 > 最新文献

Journal of Clinical Anesthesia最新文献

英文 中文
Preoperative SGLT2i therapy and acute kidney injury in patients undergoing emergency and urgent coronary artery bypass grafting - A causal inference framework 急诊和紧急冠状动脉旁路移植术患者术前SGLT2i治疗与急性肾损伤的因果推断框架
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-12-15 DOI: 10.1016/j.jclinane.2025.112103
Michael Kolland , Selina Sartori , Christoph Klivinyi , Michael Schörghuber , Jakob Pannold , Igor Knez , Alexander H. Kirsch , Nikolaus Schreiber

Background

Acute kidney injury (AKI) is a common complication after coronary artery bypass grafting (CABG), associated with adverse short- and long-term outcomes. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have been shown to reduce occurrence of AKI in several populations, yet their perioperative effects in patients undergoing CABG are unknown.

Methods

We conducted a retrospective study at the Department of Cardiac Surgery, Medical University of Graz (2020–2024) to evaluate the impact of preoperative SGLT2i use on cardiac surgery–associated AKI in adults undergoing urgent or emergent isolated coronary artery bypass grafting in patients with an indication for SGLT2i therapy (type 2 diabetes mellitus, heart failure with reduced ejection fraction, or chronic kidney disease). Patients with preoperative dialysis, sepsis, reoperation, mechanical circulatory support or missing laboratory data were excluded. Exposure was defined as SGLT2i use within two weeks before surgery, and the primary outcome was cardiac surgery-associated AKI (CSA-AKI) according to KDIGO criteria. Secondary outcomes included kidney replacement therapy, ICU length of stay, 30-day mortality and postoperative diabetic ketoacidosis. Causal effects were estimated using entropy balancing. Results were reported as weighted risk differences, risk ratios, and adjusted mean differences, with time-to-event outcomes analyzed via weighted Cox models and Kaplan–Meier estimates.

Results

Among 484 patients, 135 were on SGLT2i. CSA-AKI occurred in 23.0 % of SGLT2i users vs. 28.1 % of non-users (risk ratio of 0.63 [95 % CI 0.44–0.91; p = 0.014]). The association was pronounced in patients with heart failure with reduced ejection fraction and those with high EuroSCORE II. No differences were observed in other secondary endpoints and no cases of postoperative diabetic ketoacidosis occurred.

Conclusion

Preoperative SGLT2i use was associated with a significantly lower risk of CSA-AKI in patients undergoing urgent or emergent CABG. These findings need to be confirmed in prospective multicenter trials but underline the favorable safety profile of this medication.
背景:急性肾损伤(AKI)是冠状动脉旁路移植术(CABG)后常见的并发症,与不良的短期和长期预后相关。钠-葡萄糖共转运蛋白-2抑制剂(SGLT2i)已被证明可以减少几个人群AKI的发生,但其在CABG患者的围手术期效果尚不清楚。方法:我们在格拉茨医科大学心脏外科(2020-2024)进行了一项回顾性研究,以评估术前使用SGLT2i对有SGLT2i治疗指征(2型糖尿病、心力衰竭伴射血分数降低或慢性肾病)的成人紧急或紧急孤立冠状动脉旁路移植术中心脏手术相关AKI的影响。排除术前透析、败血症、再手术、机械循环支持或缺少实验室数据的患者。暴露被定义为术前两周内使用SGLT2i,根据KDIGO标准,主要结局是心脏手术相关AKI (CSA-AKI)。次要结局包括肾脏替代治疗、ICU住院时间、30天死亡率和术后糖尿病酮症酸中毒。利用熵平衡估计因果效应。结果报告为加权风险差异、风险比和调整后的平均差异,并通过加权Cox模型和Kaplan-Meier估计分析事件发生时间。结果:484例患者中,有135例接受SGLT2i治疗。SGLT2i使用者中CSA-AKI发生率为23.0%,非使用者中为28.1%(风险比为0.63 [95% CI 0.44-0.91; p = 0.014])。在射血分数降低的心力衰竭患者和EuroSCORE II高的患者中,这种关联明显。其他次要终点无差异,术后无糖尿病酮症酸中毒病例发生。结论:术前使用SGLT2i与急诊或紧急冠脉搭桥患者CSA-AKI风险显著降低相关。这些发现需要在前瞻性多中心试验中得到证实,但强调了该药物的良好安全性。
{"title":"Preoperative SGLT2i therapy and acute kidney injury in patients undergoing emergency and urgent coronary artery bypass grafting - A causal inference framework","authors":"Michael Kolland ,&nbsp;Selina Sartori ,&nbsp;Christoph Klivinyi ,&nbsp;Michael Schörghuber ,&nbsp;Jakob Pannold ,&nbsp;Igor Knez ,&nbsp;Alexander H. Kirsch ,&nbsp;Nikolaus Schreiber","doi":"10.1016/j.jclinane.2025.112103","DOIUrl":"10.1016/j.jclinane.2025.112103","url":null,"abstract":"<div><h3>Background</h3><div>Acute kidney injury (AKI) is a common complication after coronary artery bypass grafting (CABG), associated with adverse short- and long-term outcomes. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have been shown to reduce occurrence of AKI in several populations, yet their perioperative effects in patients undergoing CABG are unknown.</div></div><div><h3>Methods</h3><div>We conducted a retrospective study at the Department of Cardiac Surgery, Medical University of Graz (2020–2024) to evaluate the impact of preoperative SGLT2i use on cardiac surgery–associated AKI in adults undergoing urgent or emergent isolated coronary artery bypass grafting in patients with an indication for SGLT2i therapy (type 2 diabetes mellitus, heart failure with reduced ejection fraction, or chronic kidney disease). Patients with preoperative dialysis, sepsis, reoperation, mechanical circulatory support or missing laboratory data were excluded. Exposure was defined as SGLT2i use within two weeks before surgery, and the primary outcome was cardiac surgery-associated AKI (CSA-AKI) according to KDIGO criteria. Secondary outcomes included kidney replacement therapy, ICU length of stay, 30-day mortality and postoperative diabetic ketoacidosis. Causal effects were estimated using entropy balancing. Results were reported as weighted risk differences, risk ratios, and adjusted mean differences, with time-to-event outcomes analyzed via weighted Cox models and Kaplan–Meier estimates.</div></div><div><h3>Results</h3><div>Among 484 patients, 135 were on SGLT2i. CSA-AKI occurred in 23.0 % of SGLT2i users vs. 28.1 % of non-users (risk ratio of 0.63 [95 % CI 0.44–0.91; <em>p</em> = 0.014]). The association was pronounced in patients with heart failure with reduced ejection fraction and those with high EuroSCORE II. No differences were observed in other secondary endpoints and no cases of postoperative diabetic ketoacidosis occurred.</div></div><div><h3>Conclusion</h3><div>Preoperative SGLT2i use was associated with a significantly lower risk of CSA-AKI in patients undergoing urgent or emergent CABG. These findings need to be confirmed in prospective multicenter trials but underline the favorable safety profile of this medication.</div></div>","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"109 ","pages":"Article 112103"},"PeriodicalIF":5.1,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145768267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond the operating room: Holistic support for frail surgical patients. 超越手术室:为身体虚弱的外科病人提供全面的支持。
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-12-15 DOI: 10.1016/j.jclinane.2025.112095
Aubrey Samost-Williams, Alparslan Turan, Victoria Tang
{"title":"Beyond the operating room: Holistic support for frail surgical patients.","authors":"Aubrey Samost-Williams, Alparslan Turan, Victoria Tang","doi":"10.1016/j.jclinane.2025.112095","DOIUrl":"https://doi.org/10.1016/j.jclinane.2025.112095","url":null,"abstract":"","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":" ","pages":"112095"},"PeriodicalIF":5.1,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145762742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of implementing a thromboelastometry-guided transfusion strategy on fibrinogen supplementation and transfusion in women with postpartum hemorrhage 实施血栓弹性测量指导输血策略对产后出血妇女纤维蛋白原补充和输血的影响
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-12-12 DOI: 10.1016/j.jclinane.2025.112102
Anne Zheng , Valérie Chamouard , Christophe Nougier , François-Pierrick Desgranges , Charles-Hervé Vacheron , Lionel Bouvet

Study objective

Coagulopathy is a key determinant of maternal prognosis in case of postpartum hemorrhage. We sought to assess the impact of implementing a thromboelastometry-based coagulopathy management protocol on fibrinogen concentrate use and transfusion strategies.

Design

Retrospective study.

Setting

Tertiary care obstetric unit, university hospital, Lyon, France.

Patients

Adult women with postpartum hemorrhage (≥500 mL blood loss within 24 h postpartum) at a gestational age ≥ 22 weeks.

Interventions

Three distinct periods were analyzed: Period 1 (2016–2018, no viscoelastic test available), Period 2 (2019–2020, thromboelastometry available in our maternity unit) and Period 3 (2021–2023, implementation of a thromboelastometry-based coagulopathy management protocol).

Measurements

The primary endpoint was the proportion of patients receiving fibrinogen concentrate in each period. Secondary endpoints were the proportions of patients transfused with blood products within the first 24 h in each period. Adjusted odds ratios (aOR) for each outcome were estimated using bidirectional stepwise regression in a final model that included 12 preselected confounders.

Main results

A total of 3899 patients were analyzed. Period 3 and Period 2 were independently associated with significantly lower odds of fibrinogen concentrate administration compared to Period 1. The aOR was 0.19 (95 %CI: 0.14 to 0.28) for Period 3 and 0.70 (95 %CI: 0.50 to 0.98) for Period 2. Period 3 was also independently associated with significantly lower odds of transfusion of red blood cells (aOR = 0.25 [95 %CI: 0.19 to 0.33]), fresh frozen plasma (aOR = 0.17 [95 %CI: 0.09 to 0.33]) and platelet concentrates (aOR = 0.23 [95 %CI: 0.08 to 0.62]) compared to Period 1. The frequency of massive postpartum hemorrhage (≥2500 mL) did not change significantly across the three periods.

Conclusions

Implementing a thromboelastometry-guided protocol was associated with significantly reduced use of fibrinogen concentrate, red blood cells, fresh frozen plasma, and platelet concentrates, without increasing the risk of progression to massive hemorrhage. Further assessments of maternal outcomes and cost-effectiveness are required.
研究目的凝血功能障碍是影响产后出血产妇预后的重要因素。我们试图评估实施基于血栓弹性测量的凝血病管理方案对浓缩纤维蛋白原使用和输血策略的影响。DesignRetrospective研究。法国里昂大学医院三级护理产科。孕龄≥22周的成年女性产后出血(产后24小时内出血量≥500 mL)。干预措施分析了三个不同的时期:第1期(2016-2018年,没有可用的粘弹性测试),第2期(2019-2020年,我们的产科病房有血栓弹性测量)和第3期(2021-2023年,实施基于血栓弹性测量的凝血病管理方案)。主要终点是每个时期接受浓缩纤维蛋白原治疗的患者比例。次要终点是在每个时间段的前24小时内输注血液制品的患者比例。在包含12个预选混杂因素的最终模型中,使用双向逐步回归估计每个结果的调整优势比(aOR)。主要结果共分析3899例患者。与第1期相比,第3期和第2期单独使用浓缩纤维蛋白原的几率显著降低。第3期的aOR为0.19 (95% CI: 0.14至0.28),第2期为0.70 (95% CI: 0.50至0.98)。与第1期相比,第3期输血红细胞(aOR = 0.25 [95% CI: 0.19至0.33])、新鲜冷冻血浆(aOR = 0.17 [95% CI: 0.09至0.33])和血小板浓缩物(aOR = 0.23 [95% CI: 0.08至0.62])的几率也显著降低。产后大出血(≥2500 mL)的发生频率在三个时期内无明显变化。结论实施血栓弹性测量指导方案可显著减少纤维蛋白原浓缩物、红细胞、新鲜冷冻血浆和血小板浓缩物的使用,且不会增加发展为大出血的风险。需要进一步评估产妇结局和成本效益。
{"title":"Impact of implementing a thromboelastometry-guided transfusion strategy on fibrinogen supplementation and transfusion in women with postpartum hemorrhage","authors":"Anne Zheng ,&nbsp;Valérie Chamouard ,&nbsp;Christophe Nougier ,&nbsp;François-Pierrick Desgranges ,&nbsp;Charles-Hervé Vacheron ,&nbsp;Lionel Bouvet","doi":"10.1016/j.jclinane.2025.112102","DOIUrl":"10.1016/j.jclinane.2025.112102","url":null,"abstract":"<div><h3>Study objective</h3><div>Coagulopathy is a key determinant of maternal prognosis in case of postpartum hemorrhage. We sought to assess the impact of implementing a thromboelastometry-based coagulopathy management protocol on fibrinogen concentrate use and transfusion strategies.</div></div><div><h3>Design</h3><div>Retrospective study.</div></div><div><h3>Setting</h3><div>Tertiary care obstetric unit, university hospital, Lyon, France.</div></div><div><h3>Patients</h3><div>Adult women with postpartum hemorrhage (≥500 mL blood loss within 24 h postpartum) at a gestational age ≥ 22 weeks.</div></div><div><h3>Interventions</h3><div>Three distinct periods were analyzed: Period 1 (2016–2018, no viscoelastic test available), Period 2 (2019–2020, thromboelastometry available in our maternity unit) and Period 3 (2021–2023, implementation of a thromboelastometry-based coagulopathy management protocol).</div></div><div><h3>Measurements</h3><div>The primary endpoint was the proportion of patients receiving fibrinogen concentrate in each period. Secondary endpoints were the proportions of patients transfused with blood products within the first 24 h in each period. Adjusted odds ratios (aOR) for each outcome were estimated using bidirectional stepwise regression in a final model that included 12 preselected confounders.</div></div><div><h3>Main results</h3><div>A total of 3899 patients were analyzed. Period 3 and Period 2 were independently associated with significantly lower odds of fibrinogen concentrate administration compared to Period 1. The aOR was 0.19 (95 %CI: 0.14 to 0.28) for Period 3 and 0.70 (95 %CI: 0.50 to 0.98) for Period 2. Period 3 was also independently associated with significantly lower odds of transfusion of red blood cells (aOR = 0.25 [95 %CI: 0.19 to 0.33]), fresh frozen plasma (aOR = 0.17 [95 %CI: 0.09 to 0.33]) and platelet concentrates (aOR = 0.23 [95 %CI: 0.08 to 0.62]) compared to Period 1. The frequency of massive postpartum hemorrhage (≥2500 mL) did not change significantly across the three periods.</div></div><div><h3>Conclusions</h3><div>Implementing a thromboelastometry-guided protocol was associated with significantly reduced use of fibrinogen concentrate, red blood cells, fresh frozen plasma, and platelet concentrates, without increasing the risk of progression to massive hemorrhage. Further assessments of maternal outcomes and cost-effectiveness are required.</div></div>","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"109 ","pages":"Article 112102"},"PeriodicalIF":5.1,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145748518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The clinical effectiveness of preoperative screening and post-screening interventions for obstructive sleep apnea: A systematic review and meta-analysis 阻塞性睡眠呼吸暂停术前筛查和筛查后干预的临床效果:系统回顾和荟萃分析。
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-12-11 DOI: 10.1016/j.jclinane.2025.112084
Rushil Parikh HBSc , Linor Berezin MD , Aparna Saripella MSc , Ellene Yan HBSc , Bianca Pivetta MD , Khashayar Poorzargar MSc , Emmanuel Olaonipekun BSc , Marina Englesakis MLIS , Majid Nabipoor PhD , Frances Chung MD

Objectives

The objective of this systematic review and meta-analysis is to evaluate the clinical utility of preoperative screening for obstructive sleep apnea (OSA) and determine the impact of targeted interventions on reducing postoperative adverse outcomes in surgical patients identified as high risk of OSA (HR-OSA).

Methods

A comprehensive literature search was conducted across multiple databases for studies evaluating the utilization of validated OSA screening tools and OSA interventions within the surgical setting. Primary outcomes included postoperative adverse respiratory and cardiac events, delirium, length of stay (LOS), intensive care unit (ICU) admissions, 30-day readmissions, and mortality. Interventions included continuous positive airway pressure (CPAP) or auto-titration positive airway pressure (APAP) use, sleep consultation, OSA safety protocols, wrist bands, and patient education. Certain studies used a combination of these interventions for HR-OSA patients.

Results

Fifty-four studies (324,935 patients) were included. The odds of adverse postoperative respiratory complications (OR 3.59, 95 % CI: 1.73–7.43) and cardiac complications (OR 2.82, 95 % CI: 1.62–4.92) events were significantly higher, and hospital LOS was significantly longer (mean difference: 0.79 days, 95 % CI: 0.42–1.15) for HR-OSA patients than those at low risk of OSA (LR-OSA). The odds of delirium, ICU admission, and 30-day readmission were not significantly increased for HR-OSA patients. In contrast, for HR-OSA patients who received post-screening interventions such as safety protocols, education and other targeted interventions, no significant differences in respiratory complications (OR 0.86, 95 % CI: 0.56–1.31), delirium (OR 0.69, 95 % CI: 0.12–4.06), escalation of care (OR 0.86, 95 % CI: 0.62–1.18), or composite adverse events (OR 0.81, 95 % CI: 0.61–1.08) were found compared to OSA patients who received no intervention.

Conclusions

Our findings confirm HR-OSA as a risk factor for postoperative adverse events. Preoperative screening for OSA and subsequent targeted perioperative interventions and management strategies may contribute to a reduction in postoperative adverse outcomes. The current evidence regarding the efficacy of targeted interventions is limited by significant heterogeneity and sparsity of high-quality data and should be interpreted as exploratory.
目的:本系统综述和荟萃分析的目的是评估阻塞性睡眠呼吸暂停(OSA)术前筛查的临床应用,并确定有针对性的干预措施对减少OSA (HR-OSA)高危手术患者术后不良结局的影响。方法:在多个数据库中进行了全面的文献检索,以评估经过验证的OSA筛查工具和OSA干预措施在手术环境中的使用情况。主要结局包括术后不良呼吸和心脏事件、谵妄、住院时间(LOS)、重症监护病房(ICU)入院、30天再入院和死亡率。干预措施包括持续气道正压(CPAP)或自动滴定气道正压(APAP)使用、睡眠咨询、OSA安全协议、腕带和患者教育。某些研究对HR-OSA患者使用了这些干预措施的组合。结果:纳入54项研究(324,935例患者)。HR-OSA患者术后不良呼吸并发症(OR 3.59, 95% CI: 1.73-7.43)和心脏并发症(OR 2.82, 95% CI: 1.62-4.92)事件的发生率明显高于低风险OSA (LR-OSA)患者,住院时间明显更长(平均差异:0.79天,95% CI: 0.42-1.15)。HR-OSA患者谵妄、ICU住院和30天再入院的几率没有显著增加。相比之下,对于接受筛查后干预(如安全方案、教育和其他针对性干预)的HR-OSA患者,与未接受干预的OSA患者相比,呼吸并发症(OR 0.86, 95% CI: 0.56-1.31)、谵妄(OR 0.69, 95% CI: 0.12-4.06)、护理升级(OR 0.86, 95% CI: 0.62-1.18)或复合不良事件(OR 0.81, 95% CI: 0.61-1.08)均无显著差异。结论:我们的研究结果证实HR-OSA是术后不良事件的危险因素。术前筛查OSA和随后有针对性的围手术期干预和管理策略可能有助于减少术后不良后果。目前关于目标干预有效性的证据受到高质量数据的显著异质性和稀疏性的限制,应该被解释为探索性的。
{"title":"The clinical effectiveness of preoperative screening and post-screening interventions for obstructive sleep apnea: A systematic review and meta-analysis","authors":"Rushil Parikh HBSc ,&nbsp;Linor Berezin MD ,&nbsp;Aparna Saripella MSc ,&nbsp;Ellene Yan HBSc ,&nbsp;Bianca Pivetta MD ,&nbsp;Khashayar Poorzargar MSc ,&nbsp;Emmanuel Olaonipekun BSc ,&nbsp;Marina Englesakis MLIS ,&nbsp;Majid Nabipoor PhD ,&nbsp;Frances Chung MD","doi":"10.1016/j.jclinane.2025.112084","DOIUrl":"10.1016/j.jclinane.2025.112084","url":null,"abstract":"<div><h3>Objectives</h3><div>The objective of this systematic review and meta-analysis is to evaluate the clinical utility of preoperative screening for obstructive sleep apnea (OSA) and determine the impact of targeted interventions on reducing postoperative adverse outcomes in surgical patients identified as high risk of OSA (HR-OSA).</div></div><div><h3>Methods</h3><div>A comprehensive literature search was conducted across multiple databases for studies evaluating the utilization of validated OSA screening tools and OSA interventions within the surgical setting. Primary outcomes included postoperative adverse respiratory and cardiac events, delirium, length of stay (LOS), intensive care unit (ICU) admissions, 30-day readmissions, and mortality. Interventions included continuous positive airway pressure (CPAP) or auto-titration positive airway pressure (APAP) use, sleep consultation, OSA safety protocols, wrist bands, and patient education. Certain studies used a combination of these interventions for HR-OSA patients.</div></div><div><h3>Results</h3><div>Fifty-four studies (324,935 patients) were included. The odds of adverse postoperative respiratory complications (OR 3.59, 95 % CI: 1.73–7.43) and cardiac complications (OR 2.82, 95 % CI: 1.62–4.92) events were significantly higher, and hospital LOS was significantly longer (mean difference: 0.79 days, 95 % CI: 0.42–1.15) for HR-OSA patients than those at low risk of OSA (LR-OSA). The odds of delirium, ICU admission, and 30-day readmission were not significantly increased for HR-OSA patients. In contrast, for HR-OSA patients who received post-screening interventions such as safety protocols, education and other targeted interventions, no significant differences in respiratory complications (OR 0.86, 95 % CI: 0.56–1.31), delirium (OR 0.69, 95 % CI: 0.12–4.06), escalation of care (OR 0.86, 95 % CI: 0.62–1.18), or composite adverse events (OR 0.81, 95 % CI: 0.61–1.08) were found compared to OSA patients who received no intervention.</div></div><div><h3>Conclusions</h3><div>Our findings confirm HR-OSA as a risk factor for postoperative adverse events. Preoperative screening for OSA and subsequent targeted perioperative interventions and management strategies may contribute to a reduction in postoperative adverse outcomes. The current evidence regarding the efficacy of targeted interventions is limited by significant heterogeneity and sparsity of high-quality data and should be interpreted as exploratory.</div></div>","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"109 ","pages":"Article 112084"},"PeriodicalIF":5.1,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145742761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
On the Cover - Mogianos et al 封面——莫吉阿诺斯等人
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-12-11 DOI: 10.1016/S0952-8180(25)00347-2
{"title":"On the Cover - Mogianos et al","authors":"","doi":"10.1016/S0952-8180(25)00347-2","DOIUrl":"10.1016/S0952-8180(25)00347-2","url":null,"abstract":"","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"108 ","pages":"Article 112086"},"PeriodicalIF":5.1,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145732971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating sedation strategies in acute respiratory distress syndrome: A meta-analysis of inhaled versus intravenous agents 评估急性呼吸窘迫综合征的镇静策略:吸入与静脉注射药物的荟萃分析。
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-12-10 DOI: 10.1016/j.jclinane.2025.112100
Sandesh Raja , Azzam Ali , Afeera Bashir , F.N.U. Kashish , Haniah Mahboob

Introduction

Acute respiratory distress syndrome (ARDS), often requires deep sedation to facilitate lung-protective ventilation. While intravenous sedatives (e.g., propofol, midazolam) are standard, inhaled agents (e.g., sevoflurane, isoflurane) have emerged as potential alternatives and may offer advantages in titratability and lung protection. This meta-analysis compares their efficacy in ARDS management.

Methods

Following PRISMA guidelines, we systematically searched multiple databases (inception–May 2025) for randomized and observational studies comparing inhaled versus intravenous sedation in ARDS. Outcomes included ICU length of stay, ventilator-free days (VFDs), mortality, and respiratory parameters. Risk of bias was assessed using ROB-2 and Newcastle-Ottawa tools. Random-effects meta-analyses were conducted for pooled estimates.

Results

Seven studies (1349 patients) were included. Inhaled sedation significantly reduced ICU stay (mean difference [MD]: −2.07 days; 95 % CI: −3.72 to −0.41; p = 0.01) and duration of mechanical ventilation (MD: −2.62 days; 95 % CI: −4.48 to −0.76; p = 0.006). However, Inhaled sedation was associated with significantly fewer VFDs (MD: −1.82; 95 % CI: −3.41 to −0.24; p = 0.02). No mortality difference was observed (p = 0.18). Inhaled agents improved PEEP on day 1 (p < 0.00001) but increased PaCO₂ (p < 0.00001) and reduced arterial pH (p = 0.001).

Conclusion

Inhaled sedation with volatile anesthetics may offer advantages over intravenous sedation in reducing ICU stay and mechanical ventilation duration in ARDS patients. However, the associated alterations in gas exchange parameters warrant cautious interpretation. Further large-scale studies are needed to confirm these findings and to optimize sedation strategies in this population.

Clinical trial registration

Not required.

Registration

This review is registered with PROSPERO (CRD420251049792).
简介:急性呼吸窘迫综合征(ARDS),通常需要深度镇静以促进肺保护性通气。虽然静脉注射镇静剂(如异丙酚、咪达唑仑)是标准的,但吸入剂(如七氟醚、异氟醚)已成为潜在的替代品,可能在滴定性和肺保护方面具有优势。本荟萃分析比较了他们在ARDS管理中的疗效。方法:遵循PRISMA指南,我们系统地检索了多个数据库(启动至2025年5月),以比较吸入镇静和静脉镇静在ARDS中的随机和观察性研究。结果包括ICU住院时间、无呼吸机天数(vfd)、死亡率和呼吸参数。使用rob2和Newcastle-Ottawa工具评估偏倚风险。随机效应荟萃分析用于汇总估计。结果:纳入7项研究(1349例患者)。吸入镇静显著减少ICU住院时间(平均差[MD]: -2.07天;95% CI: -3.72 ~ -0.41; p = 0.01)和机械通气持续时间(MD: -2.62天;95% CI: -4.48 ~ -0.76; p = 0.006)。然而,吸入镇静与vfd显著减少相关(MD: -1.82; 95% CI: -3.41至-0.24;p = 0.02)。死亡率无差异(p = 0.18)。结论:挥发性麻醉药吸入镇静在减少ARDS患者ICU住院时间和机械通气时间方面优于静脉镇静。然而,气体交换参数的相关变化需要谨慎解释。需要进一步的大规模研究来证实这些发现并优化这一人群的镇静策略。临床试验注册:不需要。注册:本综述已在PROSPERO注册(CRD420251049792)。
{"title":"Evaluating sedation strategies in acute respiratory distress syndrome: A meta-analysis of inhaled versus intravenous agents","authors":"Sandesh Raja ,&nbsp;Azzam Ali ,&nbsp;Afeera Bashir ,&nbsp;F.N.U. Kashish ,&nbsp;Haniah Mahboob","doi":"10.1016/j.jclinane.2025.112100","DOIUrl":"10.1016/j.jclinane.2025.112100","url":null,"abstract":"<div><h3>Introduction</h3><div>Acute respiratory distress syndrome (ARDS), often requires deep sedation to facilitate lung-protective ventilation. While intravenous sedatives (e.g., propofol, midazolam) are standard, inhaled agents (e.g., sevoflurane, isoflurane) have emerged as potential alternatives and may offer advantages in titratability and lung protection. This meta-analysis compares their efficacy in ARDS management.</div></div><div><h3>Methods</h3><div>Following PRISMA guidelines, we systematically searched multiple databases (inception–May 2025) for randomized and observational studies comparing inhaled versus intravenous sedation in ARDS. Outcomes included ICU length of stay, ventilator-free days (VFDs), mortality, and respiratory parameters. Risk of bias was assessed using ROB-2 and Newcastle-Ottawa tools. Random-effects meta-analyses were conducted for pooled estimates.</div></div><div><h3>Results</h3><div>Seven studies (1349 patients) were included. Inhaled sedation significantly reduced ICU stay (mean difference [MD]: −2.07 days; 95 % CI: −3.72 to −0.41; <em>p</em> = 0.01) and duration of mechanical ventilation (MD: −2.62 days; 95 % CI: −4.48 to −0.76; <em>p</em> = 0.006). However, Inhaled sedation was associated with significantly fewer VFDs (MD: −1.82; 95 % CI: −3.41 to −0.24; <em>p</em> = 0.02). No mortality difference was observed (<em>p</em> = 0.18). Inhaled agents improved PEEP on day 1 (<em>p</em> &lt; 0.00001) but increased PaCO₂ (<em>p</em> &lt; 0.00001) and reduced arterial pH (<em>p</em> = 0.001).</div></div><div><h3>Conclusion</h3><div>Inhaled sedation with volatile anesthetics may offer advantages over intravenous sedation in reducing ICU stay and mechanical ventilation duration in ARDS patients. However, the associated alterations in gas exchange parameters warrant cautious interpretation. Further large-scale studies are needed to confirm these findings and to optimize sedation strategies in this population.</div></div><div><h3>Clinical trial registration</h3><div>Not required.</div></div><div><h3>Registration</h3><div>This review is registered with PROSPERO (CRD420251049792).</div></div>","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"109 ","pages":"Article 112100"},"PeriodicalIF":5.1,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145742721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Board w/barcode 编辑委员会/条形码
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-12-10 DOI: 10.1016/S0952-8180(25)00349-6
{"title":"Editorial Board w/barcode","authors":"","doi":"10.1016/S0952-8180(25)00349-6","DOIUrl":"10.1016/S0952-8180(25)00349-6","url":null,"abstract":"","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"108 ","pages":"Article 112088"},"PeriodicalIF":5.1,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145732970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological quality of systematic reviews on the quadratus lumborum block for cesarean section: An overview of systematic reviews 剖宫产术腰方肌阻滞系统评价的方法学质量:系统评价综述。
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-12-10 DOI: 10.1016/j.jclinane.2025.112098
Burhan Dost , Muzeyyen Beldagli , Yunus Emre Karapinar , Esra Turunc , Engin İhsan Turan , Alessandro De Cassai
{"title":"Methodological quality of systematic reviews on the quadratus lumborum block for cesarean section: An overview of systematic reviews","authors":"Burhan Dost ,&nbsp;Muzeyyen Beldagli ,&nbsp;Yunus Emre Karapinar ,&nbsp;Esra Turunc ,&nbsp;Engin İhsan Turan ,&nbsp;Alessandro De Cassai","doi":"10.1016/j.jclinane.2025.112098","DOIUrl":"10.1016/j.jclinane.2025.112098","url":null,"abstract":"","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"109 ","pages":"Article 112098"},"PeriodicalIF":5.1,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145742850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hope or erosion? Humor, cynicism, and the leadership challenge in perioperative medicine 希望还是侵蚀?幽默、玩世不恭和围手术期医学的领导力挑战。
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-12-09 DOI: 10.1016/j.jclinane.2025.112096
Benjamin Martens , Silke Mischke , Markus M. Luedi
The operating theater is an emotionally and cognitively demanding arena where anesthesiologists and surgeons operate under time pressure, uncertainty, and responsibility. Team interactions in such settings frequently reveal humor, irony, or cynicism, behaviors that represent underlying ego defense mechanisms.
We explore how defense mechanisms such as humor and cynicism affect perioperative culture, teamwork, and leadership; and to argue that self-awareness, mindfulness, and relational maturity indirectly improve clinical outcomes.
This conceptual analysis integrates psychoanalytic theories (Freud, Jung, Vaillant), developmental leadership frameworks, and empirical studies of coping, mindfulness, and culture from medicine, sport, and organizational psychology. Data from nursing and acute care suggest that psychological safety, emotional intelligence, and reflective practice correlate with performance and safety.
Defensive patterns in professional behavior are not merely interpersonal; they shape patient care. Humor, sublimation and mindfulness reflect mature defenses that sustain connection and safety. Cynicism, an immature defense, isolates and fragments teams. A mindful, reflective culture in perioperative medicine is therefore an unmeasured determinant of clinical excellence.
手术室是一个对情感和认知都有要求的场所,麻醉医师和外科医生在时间压力、不确定性和责任下进行手术。在这样的环境下,团队互动经常表现出幽默、讽刺或玩世不恭,这些行为代表了潜在的自我防御机制。我们探讨幽默和玩世不恭等防御机制如何影响围手术期文化、团队合作和领导能力;并认为自我意识,正念和关系成熟间接地改善了临床结果。这一概念分析整合了精神分析理论(弗洛伊德、荣格、瓦伦特)、发展型领导框架,以及来自医学、体育和组织心理学的应对、正念和文化的实证研究。来自护理和急症护理的数据表明,心理安全、情商和反思性实践与表现和安全相关。职业行为中的防御模式不仅仅是人际关系;他们塑造了病人的护理。幽默、升华和正念反映了维持联系和安全的成熟防御。玩世不恭是一种不成熟的防御,会孤立和分裂团队。因此,围手术期医学中有意识的、反思的文化是临床卓越的不可衡量的决定因素。
{"title":"Hope or erosion? Humor, cynicism, and the leadership challenge in perioperative medicine","authors":"Benjamin Martens ,&nbsp;Silke Mischke ,&nbsp;Markus M. Luedi","doi":"10.1016/j.jclinane.2025.112096","DOIUrl":"10.1016/j.jclinane.2025.112096","url":null,"abstract":"<div><div>The operating theater is an emotionally and cognitively demanding arena where anesthesiologists and surgeons operate under time pressure, uncertainty, and responsibility. Team interactions in such settings frequently reveal humor, irony, or cynicism, behaviors that represent underlying ego defense mechanisms.</div><div>We explore how defense mechanisms such as humor and cynicism affect perioperative culture, teamwork, and leadership; and to argue that self-awareness, mindfulness, and relational maturity indirectly improve clinical outcomes.</div><div>This conceptual analysis integrates psychoanalytic theories (Freud, Jung, Vaillant), developmental leadership frameworks, and empirical studies of coping, mindfulness, and culture from medicine, sport, and organizational psychology. Data from nursing and acute care suggest that psychological safety, emotional intelligence, and reflective practice correlate with performance and safety.</div><div>Defensive patterns in professional behavior are not merely interpersonal; they shape patient care. Humor, sublimation and mindfulness reflect mature defenses that sustain connection and safety. Cynicism, an immature defense, isolates and fragments teams. A mindful, reflective culture in perioperative medicine is therefore an unmeasured determinant of clinical excellence.</div></div>","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"109 ","pages":"Article 112096"},"PeriodicalIF":5.1,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145723559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of intravenous dexamethasone on duration of analgesia following popliteal nerve block in pediatric ankle surgery: A randomized, triple-blinded clinical trial 静脉地塞米松对小儿踝关节手术腘神经阻滞后镇痛持续时间的影响:一项随机、三盲临床试验
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-12-05 DOI: 10.1016/j.jclinane.2025.112094
Tomasz Reysner M.D. , Bahadir Ciftci Assoc Prof., M.D. , Pawel Pietraszek M.D. , Tomasz Purat M.D. , Milud Shadi M.D. Ph.D , Bartosz Musielak M.D. Ph.D , Maciej Idzior M.D. Ph.D , Przemyslaw Daroszewski M.D. Ph.D , Malgorzata Reysner M.D. Ph.D

Background

Effective postoperative pain control in pediatric foot and ankle surgery remains challenging. Popliteal nerve blocks are widely used but limited by their short duration. Systemic dexamethasone may prolong analgesia, yet evidence in pediatric regional anesthesia remains sparse.

Objective

To assess the analgesic efficacy and safety of two intravenous dexamethasone doses (0.1 mg/kg and 0.2 mg/kg) administered before a single-shot popliteal nerve block in children undergoing ankle or foot surgery.

Methods

In this randomized, triple-blinded clinical trial, 90 pediatric patients were allocated to receive either placebo, 0.1 mg/kg, or 0.2 mg/kg dexamethasone intravenously prior to popliteal nerve block. The primary outcome was time to first opioid requirement. Secondary outcomes included total opioid consumption, FLACC pain scores, inflammatory markers (NLR, PLR), blood glucose, and time to motor recovery.

Results

Both dexamethasone groups had significantly longer opioid-free intervals compared to placebo (12.3 ± 2.4 h and 13.7 ± 2.6 h vs. 7.5 ± 2.2 h; p < 0.0001). Opioid consumption was lowest in the 0.2 mg/kg group (p = 0.0292). Pain scores and inflammatory markers were consistently lower in dexamethasone groups. However, blood glucose levels increased dose-dependently, with the highest values in the 0.2 mg/kg group. Motor recovery was also delayed with dexamethasone use.

Conclusion

Intravenous dexamethasone effectively prolongs analgesia and reduces opioid requirements after pediatric foot and ankle surgery. While 0.2 mg/kg provides maximal benefit, 0.1 mg/kg may offer an optimal balance between efficacy and metabolic safety.
Trial registration: ClinicalTrials.gov (NCT05887765).
儿童足部和踝关节手术后有效的疼痛控制仍然具有挑战性。腘窝神经阻滞被广泛应用,但其持续时间短。全身性地塞米松可能会延长镇痛时间,但在小儿区域麻醉中的证据仍然很少。目的评价儿童踝关节或足部手术行腘窝神经阻滞前两次静脉注射地塞米松(0.1 mg/kg和0.2 mg/kg)的镇痛效果和安全性。方法在这项随机、三盲临床试验中,90例儿童患者在腘神经阻滞前静脉注射安慰剂、0.1 mg/kg或0.2 mg/kg地塞米松。主要终点是到达第一次阿片类药物需求的时间。次要结局包括阿片类药物总消耗量、FLACC疼痛评分、炎症标志物(NLR、PLR)、血糖和运动恢复时间。结果与安慰剂组相比,地塞米松组的无阿片类药物间隔均明显延长(分别为12.3±2.4 h和13.7±2.6 h vs. 7.5±2.2 h; p < 0.0001)。0.2 mg/kg组阿片类药物消耗最低(p = 0.0292)。地塞米松组疼痛评分和炎症指标均较低。然而,血糖水平呈剂量依赖性增加,0.2 mg/kg组血糖水平最高。使用地塞米松也延迟了运动恢复。结论静脉注射地塞米松可有效延长小儿足踝手术后的镇痛时间,减少阿片类药物的需用。虽然0.2 mg/kg提供最大的效益,但0.1 mg/kg可能提供功效和代谢安全性之间的最佳平衡。试验注册:ClinicalTrials.gov (NCT05887765)。
{"title":"Effect of intravenous dexamethasone on duration of analgesia following popliteal nerve block in pediatric ankle surgery: A randomized, triple-blinded clinical trial","authors":"Tomasz Reysner M.D. ,&nbsp;Bahadir Ciftci Assoc Prof., M.D. ,&nbsp;Pawel Pietraszek M.D. ,&nbsp;Tomasz Purat M.D. ,&nbsp;Milud Shadi M.D. Ph.D ,&nbsp;Bartosz Musielak M.D. Ph.D ,&nbsp;Maciej Idzior M.D. Ph.D ,&nbsp;Przemyslaw Daroszewski M.D. Ph.D ,&nbsp;Malgorzata Reysner M.D. Ph.D","doi":"10.1016/j.jclinane.2025.112094","DOIUrl":"10.1016/j.jclinane.2025.112094","url":null,"abstract":"<div><h3>Background</h3><div>Effective postoperative pain control in pediatric foot and ankle surgery remains challenging. Popliteal nerve blocks are widely used but limited by their short duration. Systemic dexamethasone may prolong analgesia, yet evidence in pediatric regional anesthesia remains sparse.</div></div><div><h3>Objective</h3><div>To assess the analgesic efficacy and safety of two intravenous dexamethasone doses (0.1 mg/kg and 0.2 mg/kg) administered before a single-shot popliteal nerve block in children undergoing ankle or foot surgery.</div></div><div><h3>Methods</h3><div>In this randomized, triple-blinded clinical trial, 90 pediatric patients were allocated to receive either placebo, 0.1 mg/kg, or 0.2 mg/kg dexamethasone intravenously prior to popliteal nerve block. The primary outcome was time to first opioid requirement. Secondary outcomes included total opioid consumption, FLACC pain scores, inflammatory markers (NLR, PLR), blood glucose, and time to motor recovery.</div></div><div><h3>Results</h3><div>Both dexamethasone groups had significantly longer opioid-free intervals compared to placebo (12.3 ± 2.4 h and 13.7 ± 2.6 h vs. 7.5 ± 2.2 h; <em>p</em> &lt; 0.0001). Opioid consumption was lowest in the 0.2 mg/kg group (<em>p</em> = 0.0292). Pain scores and inflammatory markers were consistently lower in dexamethasone groups. However, blood glucose levels increased dose-dependently, with the highest values in the 0.2 mg/kg group. Motor recovery was also delayed with dexamethasone use.</div></div><div><h3>Conclusion</h3><div>Intravenous dexamethasone effectively prolongs analgesia and reduces opioid requirements after pediatric foot and ankle surgery. While 0.2 mg/kg provides maximal benefit, 0.1 mg/kg may offer an optimal balance between efficacy and metabolic safety.</div><div>Trial registration: <span><span>ClinicalTrials.gov</span><svg><path></path></svg></span> (<span><span>NCT05887765</span><svg><path></path></svg></span>).</div></div>","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"109 ","pages":"Article 112094"},"PeriodicalIF":5.1,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145692699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical Anesthesia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1